Skip to Main Content

Paper Details

Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk.
JCI Insight
23
2021
ACY1, HOMA-, Kazal, Kunitz, NTR domain-containing protein, T2DM, WAP, WFIKKN2, amino acid, aminoacylase, aminoacylase 1, glucose, hemoglobin A1c, human, humans, immunoglobulin, insulin, model systems, type 2 diabetes
Author NameAffiliation
Eric KuhnBroad Institute of Harvard and MIT
Olle MelanderClinical Sciences, Lund University and Skane University Hospital
Jonathan D MosleyVanderbilt University Medical Center
Steven A CarrBroad Institute of Harvard and MIT
Steven A CarrBroad Institute of Harvard and MIT
Ramachandran S VasanBoston University School of Medicine
Ramachandran S Vasanand Blood Institute's Framingham Heart Study
Martin G LarsonBoston University School of Public Health
Martin G Larsonand Blood Institute's Framingham Heart Study
Jan Gustav SmithClinical Sciences, Lund University and Skane University Hospital
Jan Gustav SmithGothenburg University and Sahlgrenska University Hospital
Jan Gustav SmithWallenberg Center for Molecular Medicine and Diabetes Center, Lund University
Thomas J WangUniversity of Texas, Southwestern Medical Center
Thomas J WangUniversity of Texas, Southwestern Medical Center
Qiong Yang
Robert E GersztenCardiovascular Institute.
Robert E GersztenBeth Israel Deaconess Medical Center (BIDMC)
Robert E GersztenBroad Institute of Harvard and MIT
  • 1 - 18

Datasets

Release 1.2